Psychedelic Drug Treatments : Assisting the Therapeutic Process.
Material type:
- text
- computer
- online resource
- 9781937585594
- RM324.8.S477 2016
Intro -- Half Title Page -- Title Page -- Copyright Page -- Contents -- Preface -- Acknowledgments -- PART ONE An Introduction to Psychotropic and Psychedelic Drugs -- CHAPTER 1 Psychoactive Compounds -- 1. What are psychoactive drugs? -- 2. How are psychotropic drugs different from psychoactive drugs? -- 3. What are psychotherapeutic drugs? -- 4. How are psychopharmaceuticals distinguished from the other "psychos"? -- 5. What are some psychotherapeutic medications and what disorders do they treat? -- 6. How long have these medicines been used therapeutically? -- 7. What are designer drugs? -- CHAPTER 2 Psychedelic Compounds -- 8. What are psychedelic drugs? -- 9. How are psychedelics different from other hallucinogens? -- 10. What does "psychedelic" mean? -- 11. What do these alternative terms mean? -- 12. What are the various psychedelic compounds? -- 13. What are the effects of the tryptamine-based psychedelics? -- 14. What are the tryptamine psychedelics? -- 15. What are the effects of the phenethylamine-based psychedelics? -- 16. What are the phenethylamine psychedelics? -- CHAPTER 3 A Bit About the Brain -- 17. How does the brain work? -- 18. How do the neurons connect to each other? -- 19. What are neurotransmitters? -- 20. What are agonists and antagonists? -- 21. What are endogenous and exogenous substances? -- 22. What is the importance of serotonin? -- 23. What is an entheogen? -- 24. Are all psychedelic drugs entheogens? -- 25. What are entactogens or empathogens? -- CHAPTER 4 How Do Psychoactive Medications Work in the Brain? -- 26. How important are the neurotransmitters? -- 27. How do psychoactive chemicals interact with the neurotransmitters? -- 28. How do psychedelics work in the brain? -- 29. Why are psychedelics not being used as medicines? -- PART TWO A Brief History of Research Efforts.
CHAPTER 5 A Brief History: From Ages Past to Research in the Early 20th Century -- 30. When were psychedelics first discovered? -- 31. Were these plants and fungi used only in ceremonies? -- 32. When did psychedelics first come to the attention of the scientific community? -- 33. Who performed some of this earliest research and what did it entail? -- 34. When was LSD discovered? -- 35. Is it true that Hofmann's discovery of LSD was accidental? -- 36. When did LSD become available for use in psychotherapy? -- CHAPTER 6 Psychedelic Research and Pioneers in the mid-1900s -- 37. Were psychedelics being used to treat mental illnesses at this time? -- 38. What was the MK-Ultra program? -- 39. Who were some of the notable clinicians and researchers in the early part of this era? -- 40. What was Dr. Humphry Osmond's major contribution to the field? -- 41. Why was Aldous Huxley's involvement with psychedelics significant? -- 42. When did Huxley first try LSD? -- 43. Why was Alfred Hubbard called "Captain Trips"? -- 44. What research efforts were going on in the UK? -- 45. Were psychedelics being used in Europe? -- 46. Did Timothy Leary make any valid contribution in terms of research? -- 47. How did Leary become involved with psychedelics? -- 48. What was the Concord Prison study? -- 49. Why is the Marsh Chapel experiment "famous"? -- 50. Was the Marsh Chapel experiment successful? -- 51. When did Timothy Leary first experiment with LSD? -- 52. Why did Leary leave Harvard? -- CHAPTER 7 Promising Research Grinds to a Halt -- 53. Why did promising research stop? -- 54. What was it about the times that contributed to the ban on these drugs? -- 55. What was the US government's role? -- 56. What did proponents of the psychedelic movement do to interfere with research? -- 57. What was the problem with the psychedelics being used recreationally?.
58. What exactly are controlled substances? -- 59. How do psychedelics compare with other controlled substances? -- 60. How does a drug become approved and legal? -- PART THREE Current Research -- CHAPTER 8 Making Pharmaceuticals Legally Available -- 61. How does a drug become an FDA-approved, legal medicine? -- 62. What is involved in a clinical study? -- 63. What are the four phases? -- 64. What is the double-blind, placebo-controlled, randomized study? -- 65. What is meant by "set and setting," and why are they important? -- 66. Do psychedelics go through the same clinical-trial process that other pharmaceuticals go through? -- 67. Are any psychedelics currently undergoing clinical studies? -- 68. Is the MAPS organization just a group of former "hippies"? -- 69. Is all current research supported by MAPS? -- 70. What are some other organizations that are studying psychedelics? -- 71. Are pharmaceutical companies researching psychedelics or sponsoring such research? -- 72. What is the protocol for administering psychedelics to assist therapy? -- 73. Is the experience like tripping? -- CHAPTER 9 Current Research -- 74. What illnesses and disorders do researchers hope to benefit from use of psychedelic-assisted therapy? -- 75. What are the anxiety disorders that are being experimentally treated with psychedelics? -- 76. Why are studies of PTSD so important? -- 77. How do the psychedelics compare with psychotherapeutic medicines that are currently being prescribed for PTSD? -- 78. How does MDMA help treat posttraumatic stress disorder? -- 79. What are end-of-life anxiety disorder and anxiety from life-threatening illness? -- 80. How can psychedelics assist with end-of-life anxiety and life-threatening illnesses such as end-stage cancer? -- 81. What is social anxiety disorder? -- 82. How are SAD and autism linked for research with psychedelics?.
83. What is Obsessive-Compulsive Disorder? -- 84. What is it about obsessions that makes them part of a disorder? -- 85. What are compulsions? -- 86. Are psychedelics being researched to assist in the treatment of OCD? -- 87. Can psychedelics be used to treat depression? -- 88. What are cluster headaches? -- 89. Which psychedelic compounds are being researched to treat cluster headaches? -- 90. How can psychedelics be helpful in the treatment of addictions? -- CHAPTER 10 Cannabis -- 91. What about medical marijuana? -- 92. What is "Uncle Sam's Pot Farm"? -- 93. What is NIDA's role in the research on marijuana? -- 94. Is NIDA-sponsored research the only research being conducted? -- 95. What are some medical conditions that cannabis could benefit? -- 96. Can cannabis be used as a tool to assist psychotherapy? -- PART FOUR The Future of Psychedelics -- CHAPTER 11 The Future for Psychedelic-Assisted Psychotherapy -- 97. Do psychedelics really have a future in modern psychotherapeutic medicine? -- 98. Which of the psychedelic compounds seem to have the best potential for continued research? -- 99. Which seem closest to achieving legal status? -- 100. Is it possible that psychedelics can not only treat, but possibly cure? -- CHAPTER 12 Safety Issues, Side Effects, and Ethics -- 101. Is there a downside to psychedelic-assisted therapy? -- 102. Are there ethical considerations with regard to psychedelic-assisted therapy? -- CHAPTER 13 Opening the Door to a Better Understanding -- 103. How do enlightened consciousness and spirituality play a part in psychotherapy? -- 104. How can this research achieve greater acceptance? -- Summary -- Appendix -- Index.
No detailed description available for "Psychedelic Drug Treatments".
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
There are no comments on this title.